176 related articles for article (PubMed ID: 27615710)
1. Longitudinal fluctuation in mammographic percent density differentiates between interval and screen-detected breast cancer.
Strand F; Humphreys K; Eriksson M; Li J; Andersson TM; Törnberg S; Azavedo E; Shepherd J; Hall P; Czene K
Int J Cancer; 2017 Jan; 140(1):34-40. PubMed ID: 27615710
[TBL] [Abstract][Full Text] [Related]
2. Novel mammographic image features differentiate between interval and screen-detected breast cancer: a case-case study.
Strand F; Humphreys K; Cheddad A; Törnberg S; Azavedo E; Shepherd J; Hall P; Czene K
Breast Cancer Res; 2016 Oct; 18(1):100. PubMed ID: 27716311
[TBL] [Abstract][Full Text] [Related]
3. Risk factors and tumor characteristics of interval cancers by mammographic density.
Holm J; Humphreys K; Li J; Ploner A; Cheddad A; Eriksson M; Törnberg S; Hall P; Czene K
J Clin Oncol; 2015 Mar; 33(9):1030-7. PubMed ID: 25646195
[TBL] [Abstract][Full Text] [Related]
4. Digital versus screen-film mammography: impact of mammographic density and hormone therapy on breast cancer detection.
Chiarelli AM; Prummel MV; Muradali D; Shumak RS; Majpruz V; Brown P; Jiang H; Done SJ; Yaffe MJ
Breast Cancer Res Treat; 2015 Nov; 154(2):377-87. PubMed ID: 26518019
[TBL] [Abstract][Full Text] [Related]
5. Predicting interval and screen-detected breast cancers from mammographic density defined by different brightness thresholds.
Nguyen TL; Aung YK; Li S; Trinh NH; Evans CF; Baglietto L; Krishnan K; Dite GS; Stone J; English DR; Song YM; Sung J; Jenkins MA; Southey MC; Giles GG; Hopper JL
Breast Cancer Res; 2018 Dec; 20(1):152. PubMed ID: 30545395
[TBL] [Abstract][Full Text] [Related]
6. Influence of patterns of hormone replacement therapy use and mammographic density on breast cancer detection.
Chiarelli AM; Kirsh VA; Klar NS; Shumak R; Jong R; Fishell E; Yaffe MJ; Boyd NF
Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1856-62. PubMed ID: 17035392
[TBL] [Abstract][Full Text] [Related]
7. Long-term prognostic implications of risk factors associated with tumor size: a case study of women regularly attending screening.
Strand F; Humphreys K; Holm J; Eriksson M; Törnberg S; Hall P; Azavedo E; Czene K
Breast Cancer Res; 2018 Apr; 20(1):31. PubMed ID: 29669579
[TBL] [Abstract][Full Text] [Related]
8. Hormone replacement therapy, percent mammographic density, and sensitivity of mammography.
Kavanagh AM; Cawson J; Byrnes GB; Giles GG; Marr G; Tong B; Gertig DM; Hopper JL
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1060-4. PubMed ID: 15894653
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal trends in mammographic percent density and breast cancer risk.
Vachon CM; Pankratz VS; Scott CG; Maloney SD; Ghosh K; Brandt KR; Milanese T; Carston MJ; Sellers TA
Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):921-8. PubMed ID: 17507617
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal measurement of clinical mammographic breast density to improve estimation of breast cancer risk.
Kerlikowske K; Ichikawa L; Miglioretti DL; Buist DS; Vacek PM; Smith-Bindman R; Yankaskas B; Carney PA; Ballard-Barbash R;
J Natl Cancer Inst; 2007 Mar; 99(5):386-95. PubMed ID: 17341730
[TBL] [Abstract][Full Text] [Related]
11. Mammographic changes resulting from benign breast surgery impair breast cancer detection at screening mammography.
van Breest Smallenburg V; Duijm LE; Voogd AC; Jansen FH; Louwman MW
Eur J Cancer; 2012 Sep; 48(14):2097-103. PubMed ID: 22513229
[TBL] [Abstract][Full Text] [Related]
12. Mammographic non-dense area and breast cancer risk in postmenopausal women: a causal inference approach in a case-control study.
Velásquez García HA; Sobolev BG; Gotay CC; Wilson CM; Lohrisch CA; Lai AS; Aronson KJ; Spinelli JJ
Breast Cancer Res Treat; 2018 Jul; 170(1):159-168. PubMed ID: 29516373
[TBL] [Abstract][Full Text] [Related]
13. Use of hormone therapy and isoflavones and mammographic density in Spain.
Isidoro B; Lope V; Whelan D; Pedraz C; Sánchez-Contador C; Santamariña C; Moreo P; Vidal C; Salas-Trejo D; Ederra M; Aragonés N; Pérez-Gómez B; Pollán M
Menopause; 2016 May; 23(5):556-64. PubMed ID: 26731688
[TBL] [Abstract][Full Text] [Related]
14. Mammographic texture and risk of breast cancer by tumor type and estrogen receptor status.
Malkov S; Shepherd JA; Scott CG; Tamimi RM; Ma L; Bertrand KA; Couch F; Jensen MR; Mahmoudzadeh AP; Fan B; Norman A; Brandt KR; Pankratz VS; Vachon CM; Kerlikowske K
Breast Cancer Res; 2016 Dec; 18(1):122. PubMed ID: 27923387
[TBL] [Abstract][Full Text] [Related]
15. A comparison of five methods of measuring mammographic density: a case-control study.
Astley SM; Harkness EF; Sergeant JC; Warwick J; Stavrinos P; Warren R; Wilson M; Beetles U; Gadde S; Lim Y; Jain A; Bundred S; Barr N; Reece V; Brentnall AR; Cuzick J; Howell T; Evans DG
Breast Cancer Res; 2018 Feb; 20(1):10. PubMed ID: 29402289
[TBL] [Abstract][Full Text] [Related]
16. Mammographic density as a surrogate marker for the effects of hormone therapy on risk of breast cancer.
Boyd NF; Martin LJ; Li Q; Sun L; Chiarelli AM; Hislop G; Yaffe MJ; Minkin S
Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):961-6. PubMed ID: 16702377
[TBL] [Abstract][Full Text] [Related]
17. Adjusting for BMI in analyses of volumetric mammographic density and breast cancer risk.
Hudson S; Vik Hjerkind K; Vinnicombe S; Allen S; Trewin C; Ursin G; Dos-Santos-Silva I; De Stavola BL
Breast Cancer Res; 2018 Dec; 20(1):156. PubMed ID: 30594212
[TBL] [Abstract][Full Text] [Related]
18. Mammographic density and risk of breast cancer by mode of detection and tumor size: a case-control study.
Krishnan K; Baglietto L; Apicella C; Stone J; Southey MC; English DR; Giles GG; Hopper JL
Breast Cancer Res; 2016 Jun; 18(1):63. PubMed ID: 27316945
[TBL] [Abstract][Full Text] [Related]
19. Mammographic density and estimation of breast cancer risk in intermediate risk population.
Tesic V; Kolaric B; Znaor A; Kuna SK; Brkljacic B
Breast J; 2013; 19(1):71-8. PubMed ID: 23173778
[TBL] [Abstract][Full Text] [Related]
20. Mammographic density and risk of breast cancer by tumor characteristics: a case-control study.
Krishnan K; Baglietto L; Stone J; McLean C; Southey MC; English DR; Giles GG; Hopper JL
BMC Cancer; 2017 Dec; 17(1):859. PubMed ID: 29246131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
